The price of WellPoint shares climbed 3.3 percent, or $1.98, to $61.89 Monday afternoon, while Amerigroup stock soared 38 percent, or $24.51, to $88.85. The offer of $92 per share was a 43 percent premium to Amerigroup's closing price of …
Investors pushed WellPoint's stock higher following the resignation of Angela Braly as president and CEO. The Indianapolis-based Blue Cross and Blue Shield licensee, which announced Braly's departure Tuesday, saw its share …
The outlook change reflects expectations for higher leverage and lower amounts of capital as WellPoint funds stock repurchases and dividends, Moody's said in a statement. "While the operations of the company remain strong, …
Check out this research note on WellPoint from stock market analyst site Seeking Alpha. The note is titled "Someone is Loving Obamacare, Among Them WellPoint Shareholders." Highlights: While the fundamental financial picture …
WellPoint last week agreed to pay $5 million to settle a suit filed by 70,000 policyholders who were eligible but did not accept shares of Cerulean in 1996, when Blue Cross converted to a for-profit company. The original suit demanded new …
After naming Braly instead, WellPoint gave Colby the additional title of vice chairman and more stock options, a move widely believed to be incentive to stay. Braly, a lawyer with dealmaking experience and public-policy savvy but a relative …
“We do feel good about what we’ve seen thus far on the exchanges,” WellPoint CEO Joseph Swedish told stock analysts on a conference call to report 2013 financial results. “While it is early, we are encouraged by the level of applications …
Charles Pepin, an investment analyst and a vice president of T. Rowe Price Associates Inc. in Baltimore, said Price is the largest holder of WellPoint stock, with its various funds controlling about 6 percent of WellPoint's outstanding shares. …
Yet WellPoint's management contends that the company's profit picture can actually brighten -- despite the regulatory challenges -- through better cost controls. The company is backing up this sentiment with a hefty $5 billion stock